Literature DB >> 16420227

Outbreak of human metapneumovirus infection in elderly inpatients in Japan.

Haruhito Honda, Jun Iwahashi, Takahito Kashiwagi, Yoshihiro Imamura, Nobuyuki Hamada, Takehiko Anraku, Seiichiro Ueda, Tsugiyasu Kanda, Takashi Takahashi, Shigeto Morimoto.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16420227      PMCID: PMC7167045          DOI: 10.1111/j.1532-5415.2005.00575_10.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
To the Editor: Human metapneumovirus (hMPV), a newly discovered pneumovirus of the Paramyxoviridae family, has been isolated from young children with acute respiratory tract illness (RTI) in the Netherlands. Serological analyses have indicated that the prevalence of hMPV in the Dutch population is high, because virtually all children became seropositive before the age of 6, indicating that hMPV is a common and ubiquitous human pathogen. Subjects aged 65 and older were reported to account for 45.9% of Canadian patients with community‐acquired hMPV infection hospitalized for RTI. Between January 18 and 31, 2005, a cluster of eight inpatients (mean age 79; range 65–89; 6 male, 2 female) developed RTI in a 23‐bed ward in a hospital for older people in Japan. The clinical features and outcomes of the subjects are shown in Table 1. All individuals were sharing the same day‐care room on the ward. Two patients had bronchiolitis (Cases 1 and 7), five bronchitis (Cases 2–5 and 8), and one upper RTI (Case 6) based on the clinical symptoms and chest roentgenograms. Mean duration of exothermic reaction (>37.0°C) was 4 days (range 0–6). Wheezing and dyspnea were observed in only two subjects; coryza and productive cough were observed in all. White blood cell count (mean 4.1 × 109 cells/L, range 2.3–6.5 × 109), and C‐reactive protein blood levels (25.7 mg/L, range 1.7–52.9) remained low. Treatment for RTI included aminophylline, oxygen supplementation, antibiotics, and acetaminophen. All subjects showed recovery from acute RTI, although two patients newly developed asthma and secondary pneumonia (Klebsiella pneumoniae identified in sputum).
Table 1

  Clinical Features and Outcome for a Cluster of Eight Elderly Inpatients in Japan Infected with Human Metapneumovirus

No.AgeSexMain 
Cause of 
AdmissionDate of 
Onset 
(January 2005)Highest 
Body 
Temperature (°C)Exothermic 
Duration 
(>37.0°C) 
(Days)CoryzaSore 
ThroatHoarsenessCoughSputumWheezingChest 
X‐RayDyspneaMinimum 
Oxygen 
Saturation 
in Arterial 
Blood 
(%)CyanosisWhite 
Blood 
Cell 
Count 
(× 109
cells/L)C‐ 
Reactive 
Protein 
(mg/L)TreatmentOutcome
184FCyclothymic disorder1838.96(+)(+)(−)ProductiveWhite viscous(+)Hyperinflation, patchy and linear shadows in left lower field(+)88(+)352.9APAP, aminophylline, O2 (1 L/min), CTRXBA and secondary pneumonia (Klebsiella pneumoniae)
271MSenile depression2438.85(+)(+)(+)ProductiveWhite viscous(−)Patchy and linear shadows in right hilar and lower fields(−)NT(−)541.2APAP, CTRXRecovered
365MMCLI2438.55(+)(+)(−)ProductiveWhite or yellow viscous(−)No change(−)NT(−)2.339.4APAP, CTRXRecovered
474MSchizophrenia2438.14(+)(+)(+)ProductiveWhite viscous(−)NT(−)NT(−)2.31.7APAP, RXMRecovered
581FMCLI2738.64(+)(+)(+)ProductiveWhite viscous(−)NT(−)NT(−)3.39.1APAP, RXMRecovered
686MMCLI2738.54(+)(+)(−)Productive(−)(−)No change(−)NT(−)5.345APAP, RXMRecovered
789MMCLI3137.84(+)(+)(+)ProductiveWhite viscous(+)Hyperinflation(+)91(−)6.513.7APAP, aminophylline, O2 (1 L/min), CTRXBA and secondary pneumonia (K. pneumoniae)
886MMCLI3136.80(+)(+)(−)ProductiveWhite viscous(−)Linear shadows in bilateral lower fields(−)NT(−)5.43.1APAP, RXMRecovered

M=male; F=female; −=negative; +=positive; APAP=acetaminophen; O2=oxygen; CTRX=ceftriaxone; BA=bronchial asthma; NT=not tested; MCLI=multiple cerebral lacunar infarction; RXM=roxithromycin.

Clinical Features and Outcome for a Cluster of Eight Elderly Inpatients in Japan Infected with Human Metapneumovirus M=male; F=female; −=negative; +=positive; APAP=acetaminophen; O2=oxygen; CTRX=ceftriaxone; BA=bronchial asthma; NT=not tested; MCLI=multiple cerebral lacunar infarction; RXM=roxithromycin. hMPV fusion gene was detected using reverse‐transcription polymerase chain reaction (RT‐PCR) in nasal swabs from all subjects at onset. The genotype of the amplified products from every specimen was identical to that of the prototype strain (designated NL/1/99, Gene Bank accession no. AY525843), which belongs to genetic lineage B1. The results of other viral cultures, antigen tests (influenza virus A/B, adenovirus, and respiratory syncytial virus (RSV)), and RT‐PCR (RSV, parainfluenza virus (types 1–4), coronavirus, and rhinovirus) were all negative. hMPV was not found in swabs from other inpatients without RTI (n=6) in the same ward or the care workers (n=4). Immunoglobulin (Ig) G antibody to hMPV with indirect immunofluorescence assay , , was already present in serum from eight hMPVinfected patients and 10 control individuals in the acute phase. The IgG titers in six hMPVinfected subjects except Cases 4 and 7 were more than four times as high in the convalescent phase, and the titers in one of the controls were more than four times as high as in the convalescent phase. Two months after recovery of the final patient, purified protein derivative (PPD) reaction was retrospectively investigated in the hMPVinfected subjects (n=8), the controls (n=8), and the care workers (n=9). Seven individuals (87.5%) (all except Case 4) showed a negative reaction, whereas the controls and the workers showed negative rates of 37.5% and 22.2%, respectively. The clinical symptoms induced by hMPV infection in children are similar to those caused by RSV infection, ranging from mild respiratory problems to severe cough, bronchiolitis, and pneumonia. hMPV ribonucleic acid was detected in respiratory samples from hospitalized patients aged 65 and older with RTI, whereas RSV was not found in the same elderly group. A cluster of eight hMPVinfected cases with RTI was found in a hospital for older people. Thus, hMPV rather than RSV should be considered as a causative pathogen in elderly subjects with RTI. One study has reported detection of hMPV antigens in nasal secretions obtained from 48 hospitalized children with RTIs using an immunofluorescent‐antibody test (IFA). IFA is a rapid and useful test for the diagnosis of hMPV infections in children, although the sensitivity of IFA (73.3%) is lower than that of RT‐PCR. It is important to establish rapid virus detection assays, including RT‐PCR or antigen tests, especially for older people, as are currently applied for diagnosing infections with other viral pathogens, because older people with pneumonia who are infected with hMPV are at risk of death due to respiratory failure. In addition, a difference was found in the PPD reaction between the hMPVinfected patients and control subjects or care workers, although the reaction was checked retrospectively. This observation suggests that a negative PPD reaction, reflecting reduced cellular immunity, is a potential risk factor for hMPV infection, as well as tuberculosis and shingles, in older people. It is necessary to conduct a wide‐ranging prospective study to better evaluate risk factors that may be associated with hMPV infection.
  8 in total

1.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.

Authors:  Guy Boivin; Yacine Abed; Gilles Pelletier; Louisette Ruel; Danielle Moisan; Stéphanie Côté; Teresa C T Peret; Dean D Erdman; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

2.  Immunofluorescence assay for detection of human metapneumovirus-specific antibodies by use of baculovirus-expressed fusion protein.

Authors:  Nobuhisa Ishiguro; Takashi Ebihara; Rika Endo; Xiaoming Ma; Ryo Shirotsuki; Susumu Ochiai; Hiroaki Ishiko; Hideaki Kikuta
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test.

Authors:  Takashi Ebihara; Rika Endo; Xiaoming Ma; Nobuhisa Ishiguro; Hideaki Kikuta
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

4.  Human metapneumovirus infection in Japanese children.

Authors:  Takashi Ebihara; Rika Endo; Hideaki Kikuta; Nobuhisa Ishiguro; Hiroaki Ishiko; Michimaru Hara; Yutaka Takahashi; Kunihiko Kobayashi
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

5.  Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

Authors:  Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Infect Dis       Date:  2003-10-27       Impact factor: 5.226

6.  Characterization of human metapneumoviruses isolated from patients in North America.

Authors:  Teresa C T Peret; Guy Boivin; Yan Li; Michel Couillard; Charles Humphrey; Albert D M E Osterhaus; Dean D Erdman; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-05-03       Impact factor: 5.226

7.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

8.  Antigenic and genetic variability of human metapneumoviruses.

Authors:  Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

  8 in total
  23 in total

1.  Enhanced viral etiological diagnosis of respiratory system infection outbreaks by use of a multitarget nucleic acid amplification assay.

Authors:  Sallene Wong; Kanti Pabbaraju; Bonita E Lee; Julie D Fox
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

Review 2.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 3.  Severe Respiratory Viral Infections: New Evidence and Changing Paradigms.

Authors:  James M Walter; Richard G Wunderink
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

4.  Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults.

Authors:  Kyle Widmer; Yuwei Zhu; John V Williams; Marie R Griffin; Kathryn M Edwards; H Keipp Talbot
Journal:  J Infect Dis       Date:  2012-04-23       Impact factor: 5.226

Review 5.  Epidemiology of human metapneumovirus.

Authors:  Jeffrey S Kahn
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus infection in a pediatric hemato-oncology patient population.

Authors:  Sollip Kim; Heungsup Sung; Ho Joon Im; Soo-Jong Hong; Mi-Na Kim
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

Review 8.  Human metapneumovirus in adults.

Authors:  Lenneke E M Haas; Steven F T Thijsen; Leontine van Elden; Karen A Heemstra
Journal:  Viruses       Date:  2013-01-08       Impact factor: 5.048

9.  Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection.

Authors:  Krishnendu Chakraborty; Zehua Zhou; Nobuko Wakamatsu; Antonieta Guerrero-Plata
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

10.  Long-term care facilities: a cornucopia of viral pathogens.

Authors:  Ann R Falsey; Gerard E Dallal; Maria A Formica; Gloria G Andolina; Davidson H Hamer; Lynette L Leka; Simin Nikbin Meydani
Journal:  J Am Geriatr Soc       Date:  2008-06-28       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.